Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (113510)	4/8/2003 2:10:38 PM
From: StocksDATsoar	Read Replies (1) \| Respond to of 150070

COMTEX) B: MOVER(+): CRIS Tries 2nd Breakout; New Drug Candidate [delayed B: MOVER(+): CRIS Tries 2nd Breakout; New Drug Candidate [delayed] Ridgeland, MS, APR 07, 2003 (EventX/Knobias.com via COMTEX) -- Shares of Curis Incorporated (NasdaNM: CRIS) appear to be attempting another breakout to new day-highs. Earlier the Company announced that it's scientists had identified a novel small molecule drug candidate, CUR-61414, for the treatment of basal cell carcinoma (BCC), a skin cancer and the most common form of all human cancers with approximately one million new cases every year in the United States. This new development sent shares skyrocketing up over 80%. CRIS has just made another day high of $1.64, before a quick pullback. GET KNOBIAS IN REAL-TIME: Delivery of this proprietary Knobias alert has been delayed by 20 minutes. To get all Knobias alerts in real-time daily, visit knobias.com ABOUT KNOBIAS: Knobias is a financial information provider serving retail investors and trading professionals. Knobias provides customers with COMPLETE DESKTOP SOLUTIONS, including Real-time desktop applications, Real-time news & alerts via RAiDAR and a complete fundamental database covering over 13,000 stocks. CONTACT: Knobias.com, LLC 601-978-3399 601-978-3675 info@knobias.com www.knobias.com/cmtx Copyright 2002 Knobias.com, LLC, All rights reserved.